Literature DB >> 8642447

Glutamine metabolism and transport in skeletal muscle and heart and their clinical relevance.

M J Rennie1, A Ahmed, S E Khogali, S Y Low, H S Hundal, P M Taylor.   

Abstract

The glutamine and glutamate transporters in skeletal muscle and heart appear to play a role in control of the steady-state concentration of amino acids in the intracellular space and, in the case of skeletal muscle at least, in the rate of loss of glutamine to the plasma and to other organs and tissues. This article reviews what is currently known about transporter characteristics and mechanisms in skeletal muscle and heart, the alterations in transport activity in pathophysiological conditions and the implications for anabolic processes and cardiac function of altering the availability of glutamine. The possibilities that glutamine pool size is part of an osmotic signaling mechanism to regulate whole body protein metabolism is discussed and evidence is shown from work on cultured muscle cells. The possible uses of glutamine in maintaining cardiac function perioperatively and in promoting glycogen metabolism are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642447     DOI: 10.1093/jn/126.suppl_4.1142S

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  11 in total

Review 1.  ISSN exercise & sports nutrition review update: research & recommendations.

Authors:  Chad M Kerksick; Colin D Wilborn; Michael D Roberts; Abbie Smith-Ryan; Susan M Kleiner; Ralf Jäger; Rick Collins; Mathew Cooke; Jaci N Davis; Elfego Galvan; Mike Greenwood; Lonnie M Lowery; Robert Wildman; Jose Antonio; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2018-08-01       Impact factor: 5.150

2.  Adaptive metabolic response to 4 weeks of sugar-sweetened beverage consumption in healthy, lightly active individuals and chronic high glucose availability in primary human myotubes.

Authors:  Francesco Sartor; Matthew J Jackson; Cesare Squillace; Anthony Shepherd; Jonathan P Moore; Donald E Ayer; Hans-Peter Kubis
Journal:  Eur J Nutr       Date:  2012-06-26       Impact factor: 5.614

3.  Sigma receptors [σRs]: biology in normal and diseased states.

Authors:  Colin G Rousseaux; Stephanie F Greene
Journal:  J Recept Signal Transduct Res       Date:  2015-06-09       Impact factor: 2.092

4.  An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle.

Authors:  Micah J Drummond; Erin L Glynn; Christopher S Fry; Kyle L Timmerman; Elena Volpi; Blake B Rasmussen
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-02-09       Impact factor: 4.310

5.  Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome.

Authors:  Hyun Sik Jun; Young Mok Lee; Yuk Yin Cheung; David H McDermott; Philip M Murphy; Suk See De Ravin; Brian C Mansfield; Janice Y Chou
Journal:  Blood       Date:  2010-05-24       Impact factor: 22.113

6.  Aspartate transporter expression and activity in hypertrophic rat heart and ischaemia-reperfusion injury.

Authors:  Nicola King; Hua Lin; John D McGivan; M-Saadeh Suleiman
Journal:  J Physiol       Date:  2004-02-06       Impact factor: 5.182

7.  Effect of strength training session on plasma amino acid concentration following oral ingestion of leucine, BCAAs or glutamine in men.

Authors:  Antti Mero; Anne Leikas; Juha Knuutinen; Juha J Hulmi; Vuokko Kovanen
Journal:  Eur J Appl Physiol       Date:  2008-10-21       Impact factor: 3.078

8.  A metabolic model of the mitochondrion and its use in modelling diseases of the tricarboxylic acid cycle.

Authors:  Anthony C Smith; Alan J Robinson
Journal:  BMC Syst Biol       Date:  2011-06-29

Review 9.  Dietary supplements and the promotion of muscle growth with resistance exercise.

Authors:  R B Kreider
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.928

10.  Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy.

Authors:  P Rocheteau; L Chatre; D Briand; M Mebarki; G Jouvion; J Bardon; C Crochemore; P Serrani; P P Lecci; M Latil; B Matot; P G Carlier; N Latronico; C Huchet; A Lafoux; T Sharshar; M Ricchetti; F Chrétien
Journal:  Nat Commun       Date:  2015-12-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.